1. Home
  2. Directory
  3. Alabama
  4. Birmingham
  5. Neurological Surgery
  6. NPI Profile
  7. Prescriptions 1760413645

JAMES MARKERT
Prescription History 1760413645
Neurological Surgery in Birmingham, AL

NPI Status: Active since July 06, 2006

Contact Information

1717 6TH AVE S
BIRMINGHAM, AL
ZIP 35233
Phone: (800) 822-8816

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JAMES MARKERT, an active Neurological Surgery specialist practicing in Birmingham, AL. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 84 documented patient claims. Among these therapy options, the most frequently utilized medication is Gabapentin, which accounts for 41 claims alone.

Medication Index

G
L
No matching medications currently found on file.

Gabapentin

Generic Formulation: GabapentinSpecialty: Neurosurgery
Provider Metrics Summary
Total Claims 41
30-Day Fills 42.5
Days Supply 1,257
AL State Average Benchmarks
Peer Average Claims176.0
Peer Average 30-Day Fills244.6
Peer Average Days Supply7,218
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 76.7% less volume than the regional standard for practitioners inside AL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $584.29 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.25

State Avg Cost Per Claim

$18.27

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Lacosamide

Generic Formulation: LacosamideSpecialty: Neurosurgery
Provider Metrics Summary
Total Claims 30
30-Day Fills 32.0
Days Supply 960
AL State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills53.7
Peer Average Days Supply1,549
Conservative Utilization

This provider writes prescriptions for this formulation 31.8% less frequently than the standard regional baseline metric for practitioners inside AL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,133.76 across this reporting matrix range.

Provider Avg Cost Per Claim

$37.79

State Avg Cost Per Claim

$316.16

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An acetamide derivative that acts as a blocker of VOLTAGE-GATED SODIUM CHANNELS. It is used as an anticonvulsant, for adjunctive or monotherapy, in the treatment of PARTIAL SEIZURES.

Therapeutic Applications

Lacosamide is used to prevent and control seizures. It is an anticonvulsant or antiepileptic drug. It works by reducing the spread of seizure activity in the brain.

Levetiracetam

Generic Formulation: LevetiracetamSpecialty: Neurosurgery
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 305
AL State Average Benchmarks
Peer Average Claims57.0
Peer Average 30-Day Fills88.8
Peer Average Days Supply2,456
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 77.2% less volume than the regional standard for practitioners inside AL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $693.50 across this reporting matrix range.

Provider Avg Cost Per Claim

$53.35

State Avg Cost Per Claim

$38.94

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent.

Therapeutic Applications

Levetiracetam is used to treat seizures (epilepsy). It belongs to a class of drugs known as anticonvulsants. Levetiracetam may decrease the number of seizures you have.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like JAMES MARKERT provides transparency into local medical care patterns within Birmingham, AL.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Neurological Surgery** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.